Atosiban (free acid) Trifluoroacetate features a modified peptide sequence containing both cyclic and linear elements. Researchers examine its receptor-binding determinants and conformational adaptability. Charge and hydrophobic balance influence solubility and folding. Applications include structural mapping, ligand-binding studies, and sequence-engineering research.
CAT No: R2560
CAS No:168102-69-0
Synonyms/Alias:168102-69-0;Atosiban (free acid) Trifluoroacetate;2-[[(2S)-5-amino-2-[[(2S)-1-[(4R,7S,10S,16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]acetic acid;2,2,2-trifluoroacetic acid;DA-59745;
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.